Design and refine protocols that balance scientific rigor with operational feasibility and patient centricity. Paradigm Health partners with sponsors to align study design, eligibility criteria, biomarker strategy, and clinical workflows with real-world care delivery, expanding eligible and more representative patient populations while reducing burden, accelerating activation, and maximizing recruitment potential from day one.
In an effort to meet perceived regulatory expectations, protocols have become increasingly complex, often introducing design elements that fail to reflect standard of care, site capabilities, and patient eligibility realities. When study requirements become too misaligned with how care is actually delivered, high-quality community and academic sites may choose not to participate. Even when sites do engage, operational burden increases and enrollment timelines can slip. The result is mounting pressure to amend protocols midstream, adding cost and risk to already resource-intensive trials and overburdened site staff.
Study workflows, comparator arms, biomarker strategies, and schedules of events frequently diverge from routine clinical practice. This misalignment creates unnecessary friction at the site level, delaying activation and reducing a trial’s overall feasibility before enrollment even begins.
Overly narrow or poorly structured inclusion and exclusion criteria shrink the eligible patient pool and complicate screening. What appears scientifically sound on paper can significantly limit recruitment potential in practice, slowing enrollment and reducing representative participation across care settings.
Paradigm Health helps trial sponsors develop scientifically rigorous protocols built for execution, not just approval. Whether designing a study from the ground up or refining one already in motion, we align protocol strategy with site capabilities, patient populations, and care delivery realities.
We assess study design, eligibility criteria, and operational requirements against insights from our provider network and quantitative eligibility modeling to identify feasibility gaps before activation. Through site-level scenario analysis, we determine which protocol levers meaningfully expand the recruitable patient pool — and which do not. The result: stronger site fit, improved recruitment potential, and reduced amendment risk.
Whether designing a new protocol or optimizing one already underway, Paradigm Health delivers targeted, data-informed assessments to strengthen operational feasibility and clinical regulatory alignment. Findings are delivered through structured feasibility and optimization reports that support internal decision-making and regulatory alignment.
Design and model eligibility criteria to quantify impact on recruitable patient volume, demographic representation, and site-level distribution, while recommending language refinements that improve interpretability for participating sites.
Incorporate feedback from Paradigm Health’s Trial Advisory Board and network to identify feasibility risks and refine protocol design before activation.
Select comparator strategies aligned with current clinical practice to improve site fit and execution readiness.
Evaluate biomarker requirements and testing workflows to ensure efficient patient identification and reduce activation delays.
Assess schedule of activities and operational demands to reduce site burden and streamline trial execution.
Align protocol design with regulatory expectations and identify risk areas early to reduce amendment likelihood and strengthen approval potential.
By aligning study strategy, data collection requirements, and operational design with site capabilities, patient eligibility realities, and regulatory expectations, Paradigm Health helps sponsors launch with greater confidence and execute with fewer downstream surprises.
Protocols aligned with site capabilities, standard of care, and streamlined data collection—designed with Paradigm Health’s EHR-integrated conduct solutions in mind—reduce feasibility friction and improve activation timelines, enabling sites to move more efficiently toward first patient in.
Eligibility and biomarker strategies designed for real-world feasibility expand the addressable patient pool and improve recruitment performance across diverse settings.
Early identification of operational and regulatory gaps decreases the likelihood of costly mid-study protocol changes.
Whether you're designing a new study or preparing for activation, early protocol decisions shape enrollment performance, site adoption, and amendment risk. Connect with Paradigm Health to assess feasibility, strengthen execution readiness, and move forward with greater confidence.
Let’s build a protocol positioned for performance.
